| HBPV | Haemophilus influenza type B Polysaccharide(PRP) Vaccine; B형 헤모필루스 인플루엔자 피막 다당질 백신... |
|---|---|
| HDCV | Human Diploid Cell Vaccine; 인간 이배체 세포 백신 |
| NTV | Nervous Tissue Vaccine; 신경 조직 백신 |
| OPV | Oral Polio-Vaccine; 경구용 소아마비 백신 |
| TOPV | Trivalent Oral Polio(myelitis) Vaccine; 경구용 소아마비 혼합백신 |
| crystal violet vaccine | See: hog cholera vaccines. (05 Mar 2000) |
|---|---|
| Haemophilus influenza b vaccine | <virology> A vaccination that is given to infants to protect against infection with haemophilus influenza b, an important cause of neonatal sepsis. Typically administered at 2, 4, 6 and 15 months. Children who are aged 15 months to 5 years, who have not received the vaccine, should be given a single injection of haemophilus b conjugate vaccine. Acronym: HIB (26 Mar 1998) |
| Haemophilus influenzae type B vaccine | A conjugate of oligosaccharides of the capsular antigen of H. Influenzae type B and diphtheria CRM protein. (05 Mar 2000) |
| Haffkine's vaccine | A killed culture of Vibrio cholerae in two strengths, a weaker one for the initial inoculation and a stronger one for the second inoculation 7 to 10 days after the first, a killed plague bacillus (Yersinia pestis) vaccine. (05 Mar 2000) |
| sabin vaccine | Oral Polio virus Vaccine (OPV). The polio virus in opv is attenuated (weakened). The sabin vaccine is named after the american virologist albert sabin. See immunization, polio. (12 Dec 1998) |
| salk vaccine | Inactivated Polio Vaccine (IPV). The polio virus in ipv has been inactivated (killed). The salk vaccine is named after the american physician-virologist jonas salk. See immunization, polio. (12 Dec 1998) |
| hepatitis B vaccine | <virology> An injectable vaccine, given in three boosters, which offers protection from infection with hepatitis B. (27 Sep 1997) |
| heterogenous vaccine | Vaccine that is not autogenous, but is prepared from the same species of bacterium. (05 Mar 2000) |
| hib vaccine | A vaccination that is given to infants to protect against infection with haemophilus influenza b, an important cause of neonatal sepsis. Typically administered at 2, 4, 6 and 15 months. Children who are aged 15 months to 5 years, who have not received the vaccine, should be given a single injection of haemophilus b conjugate vaccine. (27 Sep 1997) |
| high-egg-passage vaccine | Living Flury strain rabies virus at the 180th to 190th level egg passage (embryonate eggs), used for vaccination of cattle and cats, low-egg-passage (LEP) vaccine: at the 40th to 50th passage level, containing 103 to 104 mouse LD50; nonpathogenic in dogs but retains some pathogenicity for cattle and cats. (05 Mar 2000) |
| Semple vaccine | A modification of the original (Pasteur) rabies vaccine, formerly widely used in the U.S., prepared from rabbit nerve tissue, inactivated with phenol and administered in 14 to 21 daily injections; has variable potency and is associated with a high incidence of postvaccinal demyelination. (05 Mar 2000) |
| human diploid cell rabies vaccine | An iodinated virus vaccine used for protection against rabies vaccine usually prepared in the human diploid cell WI-38. Synonym: human diploid cell rabies vaccine. (05 Mar 2000) |
| human diploid cell vaccine | An iodinated virus vaccine used for protection against rabies vaccine usually prepared in the human diploid cell WI-38. Synonym: human diploid cell rabies vaccine. (05 Mar 2000) |
| smallpox vaccine | A live vaccinia virus vaccine of calf lymph or chick embryo origin, used for immunization against smallpox. It is now recommended only for laboratory workers exposed to smallpox virus. Certain countries continue to vaccinate those in the military service. Complications that result from smallpox vaccination include vaccinia, secondary bacterial infections, and encephalomyelitis. (12 Dec 1998) |
| split-virus vaccine | <pharmacology> A vaccine composed of a purified antigenic determinant that is separated from the disease-causing organism. (06 Mar 1998) |